DCPH
NASDAQ
$25.59
Deciphera Pharmaceuticals Inc (DCPH)
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to improve the lives of cancer patients by addressing key drug resistance mechanisms that limit the rate and durability of response to existing cancer therapies. The company is headquartered in Waltham, Massachusetts.
Sector:
Healthcare
Target: $27.52 (+7.54%)
Market Cap
$2.24B
Free Cash Flow Yield
-6.81%
Price Chart
Valuation
Market Cap$2.24B
P/S12.79
P/B7.08
Profitability
Total Revenue (TTM)$175M
Gross Profit (TTM)-$63M
EBITDA-$205M
Profit Margin-108.9%
Operating Margin-108.5%
EPS-$2.22
Financial Health
Free Cash Flow Yield-6.81%
Growth & Risk
Sharpe Ratio1.17